Drug development is a complex, high-stakes process that shapes the future of healthcare and pharmaceutical innovation. Featured.com's expert directory showcases top professionals in this field, from pharmacologists and clinical researchers to regulatory affairs specialists. These seasoned experts have been quoted in leading scientific journals and medical publications, offering invaluable insights on drug discovery, clinical trials, and regulatory pathways. For publishers and journalists, our directory provides instant access to authoritative voices who can lend credibility to articles on breakthrough therapies or emerging industry trends. For drug development professionals, it's an opportunity to amplify their expertise and connect with major media outlets. Whether you're writing about precision medicine or the latest in biotechnology, our curated network of experts ensures you have the most current, reliable information at your fingertips. Explore our directory to find the perfect drug development expert for your next story or collaboration.
Connect directly with our network of vetted drug development experts for interviews, quotes, or in-depth analysis.
Many experts respond within hours to media requests
All experts undergo background and credential verification
No fees to connect with experts for legitimate media requests
Join our network of professionals and connect with journalists and publishers looking for your expertise.
Showing 20 of 775 experts
Founder and Managing Principal at Ter-Antonyan Consulting LLC
Vardan Ter-Antonyan is a pharmaceutical research and development executive with more than 20 years of experience advancing products from concept through commercialization. His expertise spans drug formulation, pharmaceutical development, manufacturing scale-up, quality systems, regulatory strategy, and commercialization across pharmaceuticals, medical devices, nutraceuticals, cannabinoids, and medical technologies. Throughout his career, Vardan has led multidisciplinary R&D teams, developed novel drug delivery systems, optimized manufacturing processes, and helped organizations bring innovative products to market while navigating complex regulatory requirements. His technical expertise includes lipid-based drug delivery systems, nanoemulsions, self-emulsifying drug delivery systems (SEDDS/SNEDDS), liposomes, controlled-release technologies, and formulation development for poorly water-soluble compounds. In addition to his scientific leadership, Vardan is passionate about bridging the gap between research and commercial success. He regularly advises companies on product development strategy, technology commercialization, operational excellence, and innovation management. His work combines deep scientific knowledge with practical business insight, enabling organizations to accelerate development timelines, improve product quality, and reduce technical risk. Vardan is also an author, speaker, and industry thought leader who enjoys sharing evidence-based perspectives on pharmaceutical innovation, drug delivery, biotechnology, diagnostics, manufacturing, and executive leadership. He welcomes opportunities to provide expert commentary for journalists covering advances in pharmaceutical science, healthcare innovation, biotechnology, regulatory affairs, and emerging medical technologies.
Connectively In:
CEO at Pacific Formulations
I am an entrepreneur and business leader with extensive experience building, scaling, and exiting nationally recognized dietary supplement and weight management brands. My background spans supplement manufacturing, product development, formulation strategy, operations, supply chain, direct-to-consumer marketing, and brand growth within the wellness industry. I have founded and grown multiple consumer health brands from concept through commercialization and acquisition, including Pounds Off, Lipozene, Inmit Fasting, and Fiber Thin. Throughout my career, I have led product innovation, manufacturing partnerships, regulatory compliance, quality assurance, customer acquisition, e-commerce growth, retail expansion, and large-scale direct response marketing campaigns. My expertise lies in turning product ideas into scalable businesses by aligning formulation, manufacturing, marketing, operations, and financial strategy. I have built high-performing teams, negotiated strategic partnerships, launched new product lines, optimized retention strategies, and led successful merger, acquisition, and exit transactions. I bring a practical, growth-focused perspective to supplement brand development, helping companies identify opportunities, improve operational efficiency, strengthen product-market fit, and increase long-term enterprise value.
Connectively In:
Founder & CEO at DERMA-CODE LLC
Hello, I'm Gabrielle M., Founder and CEO of DERMA-CODE™ LLC. I co-authored Skincare Through Biology Made Simple with Dr. Mohan Muvvala, DO, MBA a peer-reviewed educational resource designed to close the gap between what consumers are told and what the science actually says. DERMA-CODE™ has been featured in Skin Inc. magazine, and I've been actively contributing pieces to Skin Inc. over the past several months. DERMA-CODE™ is a biotech skincare brand launched in November 2025 built around one principle: skincare should be grounded in biology, not marketing. The brand develops fully proprietary formulations with disclosed active percentages, no white labeling, and no paid placements. Our two hero products the PDRN + NAD+ Pulse Serum and Locked-In Moisturizer are currently undergoing an active REB-approved third-party clinical study using instrumented skin measurement and blinded dermatologist grading. I speak on ingredient science, formulation integrity, clinical evaluation, and the disconnect between industry claims and published research. When you quote me, you’re not getting a brand rep reading from a script. You’re getting a founder who has spent years inside the science working alongside a team of researchers to understand exactly how ingredients behave, how formulations are built, and where the industry falls short. Every answer I give is grounded in published research and real formulation experience. I don’t guess, I don’t generalize, and I don’t send talking points. If I’m the right source for your story, you’ll know it from my first response.
Connectively In:
Co-Founder & Chief Medical Strategy Officer at Healthi-life.com
Dr. Sarassawadee Suwanjinda ("Dr. Petch") is Co-Founder and Chief Medical Strategy Officer at Healthi Life, Bangkok's Urban Longevity House. Certifications: - International Board of Lifestyle Medicine (IBLM) - International Society for Stem Cell Application (ISSCA) - Certified Board of Anti-Aging Medicine (CBAM) - American Academy of Aesthetic Medicine (AAAM) - Certificate in Aesthetic Medicine 10+ years of clinical experience in longevity, regenerative, functional, and lifestyle medicine. Available for expert medical commentary on: - Longevity medicine and healthspan extension - Stem cell and exosome therapy safety - NAD+ IV therapy and mitochondrial health - Peptide therapy and physician oversight (Tirzepatide, Retatrutide, BPC-157) - Hormone optimization (testosterone, perimenopause) - 300+ biomarker health check-ups - Functional medicine for chronic conditions Located in Ekkamai, Bangkok. Serving 50+ nationalities.
Connectively In:
Clinical Advisor at Marietta Springs
Dr. Brian Honeyman, MD, PhD, is a board-certified physician in Hospice and Palliative Medicine and Internal Medicine, with a career spanning clinical leadership, medical education, and translational research. He currently serves as a Clinical Advisor at Marietta Springs, where he helps guide compassionate, evidence-based approaches to patient care and recovery. Dr. Honeyman most recently served as Chief of Palliative Medicine for Care New England Medical Group, advancing holistic and patient-centered models of serious illness care. In addition to his clinical leadership, Dr. Honeyman is a dedicated educator and former Assistant Professor of Medicine at Brown University, where he mentored medical students, residents, and interdisciplinary learners. A graduate of the Boston University School of Medicine MD/PhD program, his doctoral research explored the molecular mechanisms of breast cancer, with publications in PLOS One and Chemistry & Biology.
Connectively In:
Independent Pharmaceutical Researcher & Founder at BuyModa.net
Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.
Senior Director of Learning and Development at Precision Medicine Group
I’m an accomplished talent development and learning professional, experienced in all aspects of learning and development and leadership development. Including assessment, design, development, delivery and evaluation. In addition I’m a dynamic trainer / facilitator with over 20 years of professional experience.M. Ed. in Training and Adult Learning, DDI Master Certified.Specialties:-Training Assessment / Analysis (working with SME's)-Instructional Design / Development -elearning and podcasting-Training Delivery (Instruction and Facilitation)-Virtual training delivery (WebEx, LearningLive, Zoom)-Sales / Business Development / Customer Service-Leadership-Motivation-Emotional Intelligence-Presentation Skills-Conflict Management-Difficult Conversations-Coaching-Time Management-Onboarding
Connectively In:
Director of Product Development & Quality Control at JustKana
I entered the hemp space at the very beginning when there were almost no guardrails, no industry playbook, and very few operators who truly understood what it took to formulate something that actually worked. Hemp-derived flower and hemp wellness products were barely a category. What existed was largely untested, poorly sourced, and built around novelty rather than need. From day one, our approach was different purpose before profit, formulation before marketing, and a deep belief that every formulation should serve a real purpose. At JustKana, I oversee product development, quality control, and sourcing from the ground up. That means building relationships directly with small-batch organic hemp farms, evaluating raw material quality before it ever reaches a formulation stage, and ensuring every finished product meets both our internal standards and third-party lab verification. My work lives at the intersection of plant science and consumer wellness. I specialize in cannabinoid formulation for real therapeutic outcomes sleep support, chronic pain relief, anxiety management, and inflammation using full-spectrum hemp extracts that preserve the natural compound profile of the plant rather than isolating single ingredients. Over the years I've helped develop products that have made a measurable difference for thousands of people veterans managing PTSD, seniors dealing with chronic joint pain, and individuals looking to replace pharmaceutical sleep aids with something cleaner and plant-derived. That direct connection to consumer outcomes shapes every formulation decision I make. I understand the hemp supply chain from soil to finished product cultivation practices, extraction methods, cannabinoid and terpene profiles, and how sourcing decisions downstream directly impact what a customer experiences. In a space flooded with white-labeled, mass-produced products, that depth of knowledge is rare.
Connectively In:
Chief Medical Officer at Modex Therapeutics
Dr. Giovanni Abbadessa is a seasoned oncology developer with over 20 years of experience in advancing innovative therapies across biotech, pharmaceutical, and nonprofit sectors. He joined ModeX Therapeutics as Chief Medical Officer, where he leads the development of the company’s multispecific biologics for cancer and infectious diseases. Prior to ModeX, Dr. Abbadessa was Vice President and Head of Oncology Early Development at Sanofi, where he spearheaded the clinical development of 16 experimental oncology drugs, guiding them from first-in-human studies through to Phase 2 trials. He established a dynamic team of 25 professionals and played a pivotal role in in-licensing 10 clinical assets. Dr. Abbadessa contributed to strategic oversight across multiple portfolios, including Phase 3 assets and partnerships, and collaborated with Investor Relations on oncology-focused initiatives.
Travel Insurance Expert at Yonder Travel Insurance
I’ve spent over seven years at Yonder Travel Insurance mastering the 'fine print' so travelers don't have to. My expertise lies in deconstructing complex policy language into clear, actionable advice, whether I’m recommending the ideal plan for a unique itinerary or guiding a client through the intricacies of the claims process. By maintaining key partnerships with top insurance providers, I stay at the forefront of industry trends to provide unbiased, expert insights that help travelers maximize their benefits and navigate the unexpected with confidence. I use this experience to craft insightful responses on behalf of Yonder to further educate the public on travel insurance, which you can explore in my featured articles section.
Connectively In:
Clinical Advisor at Aura Wellness
Dr. Shernell Surratt-Gary, D.O., is a Tulsa, Oklahoma native whose journey reflects both determination and dedication. She graduated from the University of Tulsa with a Bachelor of Science in Biological Sciences, where her interest in medicine and the human body deepened. Before matriculating to medical school, Shernell gained valuable hands-on experience at Ascension St. John, working first in the pathology department and later in the catheterization lab. These formative roles not only strengthened her technical skills but also gave her a deep appreciation for the teamwork and precision required in healthcare. She went on to earn her Doctor of Osteopathic Medicine degree from OSU Center for Health Sciences, furthering her commitment to understanding health, science, and the human experience. In addition, she served as a Family Medicine Content Author for Rosh Review, LLC, contributing to medical education and board review resources for resident physicians. Dr. Surratt-Gary currently serves as a clinical advisor for Aura Wellness, a drug, alcohol & mental health treatment center in Kentucky. Beyond her academic and professional path, Shernell embraces family life with joy. She lives with her husband and their two children, cherishing the laughter, love, and everyday moments they share together.
Connectively In:
CEO_CoFounder at Healthi Life
Vincent Caradec is the French CEO and Co-Founder of Healthi Life (healthi-life.com), Bangkok's Urban Longevity House — a physician-led longevity, preventive and regenerative medicine clinic serving 50+ nationalities. Available for expert commentary on: - Building a longevity clinic in Asia - Medical tourism market trends in Thailand and Southeast Asia - CEO insights on preventive medicine adoption - GLP-1 weight management market (Tirzepatide, Retatrutide, Mounjaro, Wegovy) - Stem cell, exosome and NAD+ regenerative therapies - 300+ biomarker testing programs and longevity diagnostics - Wellness industry business strategy and pricing - Asian healthcare entrepreneurship Healthi Life operates an integrated longevity center offering check-ups, 3-12 month longevity programs, corporate wellness contracts and advanced regenerative therapies (stem cells, exosomes, NAD+, peptides, IV therapy). French national based in Bangkok. Fluent in English and French. Available for interviews on Zoom, Google Meet, WhatsApp.
Connectively In:
Registered Pharmacist | Freelance Medical & Scientific Writer | 15+ years of remote work experience at Medical Reference
Imtiaz Ibne Alam, B.Pharm, RPh, is a registered pharmacist and freelance medical writer with 15+ years of experience across healthcare, pharmaceutical writing and scientific communication. He writes and edits peer-reviewed manuscripts, systematic reviews, pharmacovigilance and drug safety documents, regulatory and CMC content and patient education on topics such as diabetes and glucose monitoring. He has supported 20+ indexed publications and is a named co-author in the Journal of Integrative Medicine. He is available to comment on medical writing, publication ethics, drug safety, evidence-based health content and the responsible use of AI in medical writing.
Connectively In:
Founder, Managing Director at nCase Tech
At the intersection of medicine and entrepreneurship, my journey at Washington University School of Medicine molds me into a healthcare innovator. With a focus on emergency response and problem-solving, I co-founded nCase Technologies, where we've championed the creation of NALOX-1, revolutionizing how naloxone is carried and accessed. My commitment extends to shaping the future of medical education, leveraging intelligent tutoring systems to enhance learning. As a medical student, I'm empowered by a scholarship recognizing my academic prowess and leadership, and I am dedicated to integrating advanced solutions into healthcare, aiming to improve outcomes and foster community resilience.
Connectively In:
Founder at My Peptide Match
Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.
Founder, IngredientMD at IngredientMD
Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.
Connectively In:
Founder at Evidence Based Longevity
ABAAHP Diplomate and founder of Evidence Based Longevity (evidencebasedlongevity.co), a free clinical evidence platform that grades supplements exclusively by human randomized controlled trial data. The platform maps 137 medication-nutrient depletions across 50+ drug classes, provides NNT/NNH context for 11 medication categories, and includes interactive tools for stack auditing, biomarker-tracked dose optimization, and deprescribing support — all cited to 130+ PubMed references. Areas of expertise: evidence-based supplement grading, medication-nutrient interactions, deprescribing frameworks, longevity biomarker optimization, NNT/absolute risk transparency, polypharmacy and nutrient depletion, functional medicine evidence standards, consumer health technology. Available to comment on: supplement safety and efficacy, medication side effects and nutrient depletions, the gap between relative and absolute risk in prescribing, evidence standards in longevity medicine, and how patients can prepare for informed conversations with their physicians.
Connectively In:
Clinical Advisor at Alpas Wellness
Dr. Ayesha Bryant, M.S.P.H, M.D. is a physician, clinical scientist, and associate professor dedicated to translating complex medical research into practical health solutions. With more than 100 peer-reviewed publications and multiple textbook chapters, Dr. Bryant is recognized for her contributions to perioperative outcomes research, preventive medicine, and quality-of-life improvement. She currently serves as a clinical advisor at Alpas Wellness, a drug, alcohol & mental health treatment center in Maryland. She completed her medical training at the University of Alabama at Birmingham School of Medicine and Emory University, with additional training in epidemiology and public health. Her research has been featured at major national and international conferences, including the Society of Thoracic Surgeons and the American Association for Thoracic Surgery. Dr. Bryant’s expertise spans functional medicine, AI-driven healthcare algorithms, and national clinical data registry research. She is passionate about combining evidence-based medicine with real-world wellness strategies to improve patient outcomes and preventive care. In addition to her academic work, she has written for Rupa Health, where she shares insights on how readers can live healthier, more vibrant lives.
Connectively In:
CEO & CMO at Paramount Wellness Retreat
I am the CEO and Chief Marketing Officer of Paramount Wellness Retreat, where I've dedicated over 12 years to advancing behavioral health and helping individuals find their path to recovery. My journey in this field has been driven by a hands-on approach and a commitment to innovative strategies, making Paramount Wellness Retreat a beacon of hope for those struggling with mental health and substance abuse. My background in marketing, research, and team-building has been invaluable in navigating the substance abuse treatment industry, allowing me to build effective leadership teams and enhance the operational efficiency of our programs. I am deeply passionate about behavioral health and am grateful for the opportunity to make a positive impact on the lives of countless individuals seeking recovery.
Connectively In:
RPh, ABAAHP at Fusion Medical Care
I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.
Connectively In:
Showing 20 of 775 experts
Featured.com connects pharmaceutical companies with a diverse network of drug development experts, including pharmacologists, toxicologists, and clinical trial specialists. Our platform allows you to quickly identify and reach out to professionals with specific expertise in areas such as target identification, lead optimization, preclinical studies, and regulatory affairs. This targeted approach helps streamline the expert consultation process, potentially accelerating your drug development timeline.
Being listed on Featured.com offers drug development experts significant visibility to top publishers and pharmaceutical companies. This exposure can lead to opportunities for providing expert quotes, participating in interviews, or offering consultations on cutting-edge projects. By sharing your expertise through our platform, you can enhance your professional reputation, expand your network within the industry, and potentially open doors to new research collaborations or career advancement opportunities.
Publishers frequently seek expert insights on a range of drug development topics, including: latest advancements in drug discovery technologies, challenges in clinical trial design and patient recruitment, strategies for overcoming the blood-brain barrier in CNS drug development, applications of artificial intelligence in drug design, regulatory challenges in bringing new therapies to market, and emerging trends in personalized medicine. Experts who can provide clear, authoritative perspectives on these complex topics are particularly valuable to publishers looking to create in-depth, informative content.
Publishers can find a wide range of drug development experts on Featured.com, including but not limited to: medicinal chemists, pharmacokineticists, drug safety specialists, biostatisticians, and regulatory affairs professionals. Our platform also features experts in emerging areas such as biologics, gene therapies, and personalized medicine. This diverse pool of professionals ensures that publishers can access authoritative insights on various aspects of the drug development process, from early-stage research to post-market surveillance.